News Headlines Article

Melanoma drug a success, but cost is steep
Orange County Register

For a long time, research on drugs aimed at extending the lives of patients with late-stage melanoma had essentially stagnated. That all changed recently when the FDA approved a drug called Yervoy, which clinical trials showed can add months of life for patients with the advanced stage of the disease. The drawback is that the cost of the full treatment – four infusions administered over a three-month period – is about $120,000, according to its manufacturer, Bristol-Myers Squibb. The New York Times reports that the company said that other drugs cost about the same and aren’t as effective as Yervoy. It also said it would subsidize the costs for some patients.